Windlas Biotech Ltd. is a significant player in the pharmaceuticals and biotechnology industry, specializing in the manufacturing and marketing of a variety of complex dosage forms. The company primarily focuses on two segments: Contract Development and Manufacturing Organization (CDMO) Services and Over-The-Counter (OTC) Products. CDMO services offered by Windlas Biotech provide end-to-end solutions for pharmaceutical companies, from development and technical transfer to commercial manufacturing and packaging. This enables partners to efficiently bring new drugs to the market. Windlas Biotech is instrumental in addressing the needs of large pharmaceutical firms by helping them deliver timely medical solutions and maintain quality standards. Headquartered in India, the company has garnered attention for its innovation in complex formulations and stringent quality control. Windlas Biotech plays a critical role in the supply chain of the pharmaceutical sector, collaborating with diverse international clients to support the creation of affordable and effective therapeutic solutions. Its contribution to both domestic and international markets underscores its commitment to advancing global health and wellness through continuous innovation and adherence to high industry standards.